Anaplerotic therapy of huntington disease and other polyglutamine diseases
AssigneeInserm (Institut National De La Sante Et De La Recherche Medicale)
InventorsAlexandra DURR, Fanny MOCHEL
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine disease, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof.
Claims13
1-6. (canceled)
A method of treating Huntington's disease, the method comprising administering to a patient in need of such treatment a composition comprising triheptanoin.
A method of treating spinal and bulbar muscular atrophy (SBMA), the method comprising administering to a patient in need of such treatment a composition comprising triheptanoin.
Dependencies are inferred from the claim text.